Immune thrombocytopenic purpura (ITP) in children is a common pediatric bleeding disorder with heterogeneous manifestations and a natural history that is not fully understood. To better understand the natural history of chronic ITP and detect response trends and outcomes of therapy, we conducted a 10-year retrospective survey of children from age 1 to 18 years with a diagnosis of chronic ITP.
Division of Pediatric Hematology/Oncology, Department of Pediatrics, Stollery Children's Hospital, University of Alberta, Alberta, Canada. mfb10@ualberta.ca
